Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Current Leases: 2011-2025

Historic Current Leases for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $976,000.

  • Niagen Bioscience's Current Leases fell 3.17% to $976,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $976,000, marking a year-over-year decrease of 3.17%. This contributed to the annual value of $982,000 for FY2024, which is 42.11% up from last year.
  • Per Niagen Bioscience's latest filing, its Current Leases stood at $976,000 for Q3 2025, which was up 1.99% from $957,000 recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Current Leases peaked at $1.0 million during Q3 2024, and registered a low of $447,000 during Q3 2021.
  • For the 3-year period, Niagen Bioscience's Current Leases averaged around $882,000, with its median value being $939,000 (2025).
  • In the last 5 years, Niagen Bioscience's Current Leases dropped by 26.11% in 2021 and then spiked by 53.02% in 2022.
  • Niagen Bioscience's Current Leases (Quarterly) stood at $528,000 in 2021, then grew by 28.79% to $680,000 in 2022, then rose by 1.62% to $691,000 in 2023, then skyrocketed by 42.11% to $982,000 in 2024, then dropped by 3.17% to $976,000 in 2025.
  • Its Current Leases stands at $976,000 for Q3 2025, versus $957,000 for Q2 2025 and $939,000 for Q1 2025.